Literature DB >> 9676680

Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet.

T Jefferson1, R Smith, Y Yee, M Drummond, M Pratt, R Gale.   

Abstract

CONTEXT: Editorial management of articles on health economics may benefit from guidelines for peer review and revision.
OBJECTIVE: To assess whether publication (in August 1996) of the BMJ guidelines on peer review of economics submissions made any difference to editorial and peer review processes, quality of submitted manuscripts, and quality of published manuscripts. DESIGN AND
SETTING: Before-after study conducted in the editorial offices of BMJ and The Lancet of the effect of the BMJ guidelines on review and revision of economics submissions, defined as those making explicit comments about resource allocation and/or costs of interventions. MAIN OUTCOME MEASURES: Editorial fate and changes in the quality of submissions.
RESULTS: A total of 2982 manuscripts were submitted to the 2 journals during the before periods, 105 (3.5%) of which were economics submissions. Of these, 27 (24.3%) were full economics evaluations, and 78 (75.7%) were other economics submissions. Overall acceptance rate was 11.6% (12/105). During the after period 2077 manuscripts were submitted to the 2 journals, 87 (4.2%) of which were economics submissions. Eighteen (20.7%) were full economics evaluations, and 69 (79.3%) were other economics submissions. Overall acceptance rate was 6.9% (6/87). Although a number of manuscripts could not be traced to determine whether they were economics submissions, there appeared to be little difference between the 2 journals in numbers or editorial fate of the manuscripts. There was no change in the quality of submitted manuscripts, but BMJ editors found the guidelines and checklists useful and sent fewer economics submissions for external peer review in the after phase.
CONCLUSIONS: Publication of the guidelines helped the BMJ editors improve the efficiency of the editorial process but had no impact on the quality of economics evaluations submitted or published.

Mesh:

Year:  1998        PMID: 9676680     DOI: 10.1001/jama.280.3.275

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

1.  Structuring the discussion of scientific papers. Results of single studies must be assessed in context of relevant systematic reviews.

Authors:  T Jefferson
Journal:  BMJ       Date:  1999-08-28

Review 2.  Communication of socioeconomic research findings.

Authors:  R J Milne
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

3.  Quality of economic evaluations in health care.

Authors:  Tom Jefferson; Vittorio Demicheli
Journal:  BMJ       Date:  2002-02-09

4.  A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

5.  Developing and evaluating criteria to help reviewers of biomedical informatics manuscripts.

Authors:  Elske Ammenwerth; Astrid C Wolff; Petra Knaup; Hanno Ulmer; Stefan Skonetzki; Jan H van Bemmel; Alexa T McCray; Reinhold Haux; Casimir Kulikowski
Journal:  J Am Med Inform Assoc       Date:  2003-06-04       Impact factor: 4.497

6.  Reporting pharmacoeconomic evaluations.

Authors:  C I Carswell; J A Paladino
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

7.  Transparency of economic evaluations of health technologies.

Authors:  Joan Rovira
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 8.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies.

Authors:  J A Barber; S G Thompson
Journal:  BMJ       Date:  1998-10-31

Review 9.  Methodological quality of economic modelling studies. A case study with hepatitis B vaccines.

Authors:  T Jefferson; V Demicheli
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

10.  Lumbar spinal fusion patients' demands to the primary health sector: evaluation of three rehabilitation protocols. A prospective randomized study.

Authors:  Rikke Soegaard; Finn B Christensen; Ida Lauerberg; Ida Lauersen; Cody E Bünger
Journal:  Eur Spine J       Date:  2005-06-04       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.